The ups, downs and new trends of IDO1 inhibitors.
Sign Up to like & getrecommendations! Published in 2021 at "Bioorganic chemistry"
DOI: 10.1016/j.bioorg.2021.104815
Abstract: Cancer immunotherapy has become an emerging driving force in the development of innovative strategies to fight against cancer. Despite the significant clinical benefits that many cancer patients have gained, the generally average response rate of ~ 20%… read more here.
Keywords: new trends; downs new; ups downs; ido1 inhibitors ... See more keywords